NCT01018745View on ClinicalTrials.gov

Multiple Ascending Dose Study of BMS-907351 (XL184) in Patients With Solid Tumors in Japan

PHASE1CompletedINTERVENTIONAL
Enrollment

3

Participants

Timeline

Start Date

January 31, 2010

Primary Completion Date

July 31, 2010

Study Completion Date

July 31, 2010

Conditions
Neoplasms
Interventions
DRUG

BMS-907351 (XL184)

Capsules, Oral, 25, 50, 75, 100, 125 and 175 mg, Once daily, Until disease progression or unacceptable toxicity became apparent

Trial Locations (1)

104-0045

Local Institution, Chuo-Ku

Sponsors
All Listed Sponsors
lead

Bristol-Myers Squibb

INDUSTRY

NCT01018745 - Multiple Ascending Dose Study of BMS-907351 (XL184) in Patients With Solid Tumors in Japan | Biotech Hunter | Biotech Hunter